Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunotherapy of renal cell carcinoma.
Gouttefangeas C, Stenzl A, Stevanović S, Rammensee HG. Gouttefangeas C, et al. Among authors: stevanovic s. Cancer Immunol Immunother. 2007 Jan;56(1):117-28. doi: 10.1007/s00262-006-0172-4. Epub 2006 May 5. Cancer Immunol Immunother. 2007. PMID: 16676181 Free PMC article. Review.
CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors.
Dittmann J, Keller-Matschke K, Weinschenk T, Kratt T, Heck T, Becker HD, Stevanović S, Rammensee HG, Gouttefangeas C. Dittmann J, et al. Among authors: stevanovic s. Cancer Immunol Immunother. 2005 Aug;54(8):750-8. doi: 10.1007/s00262-004-0640-7. Epub 2004 Dec 22. Cancer Immunol Immunother. 2005. PMID: 15614528 Free PMC article.
Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy.
Krüger T, Schoor O, Lemmel C, Kraemer B, Reichle C, Dengjel J, Weinschenk T, Müller M, Hennenlotter J, Stenzl A, Rammensee HG, Stevanović S. Krüger T, et al. Among authors: stevanovic s. Cancer Immunol Immunother. 2005 Sep;54(9):826-36. doi: 10.1007/s00262-004-0650-5. Epub 2004 Dec 31. Cancer Immunol Immunother. 2005. PMID: 15627209 Free PMC article.
Potent costimulation of human CD8 T cells by anti-4-1BB and anti-CD28 on synthetic artificial antigen presenting cells.
Rudolf D, Silberzahn T, Walter S, Maurer D, Engelhard J, Wernet D, Bühring HJ, Jung G, Kwon BS, Rammensee HG, Stevanović S. Rudolf D, et al. Among authors: stevanovic s. Cancer Immunol Immunother. 2008 Feb;57(2):175-83. doi: 10.1007/s00262-007-0360-x. Epub 2007 Jul 27. Cancer Immunol Immunother. 2008. PMID: 17657490 Free PMC article.
HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
Stickel JS, Weinzierl AO, Hillen N, Drews O, Schuler MM, Hennenlotter J, Wernet D, Müller CA, Stenzl A, Rammensee HG, Stevanović S. Stickel JS, et al. Among authors: stevanovic s. Cancer Immunol Immunother. 2009 Sep;58(9):1407-17. doi: 10.1007/s00262-008-0655-6. Epub 2009 Feb 1. Cancer Immunol Immunother. 2009. PMID: 19184600 Free PMC article.
Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation.
Widenmeyer M, Shebzukhov Y, Haen SP, Schmidt D, Clasen S, Boss A, Kuprash DV, Nedospasov SA, Stenzl A, Aebert H, Wernet D, Stevanović S, Pereira PL, Rammensee HG, Gouttefangeas C. Widenmeyer M, et al. Among authors: stevanovic s. Int J Cancer. 2011 Jun 1;128(11):2653-62. doi: 10.1002/ijc.25601. Epub 2010 Oct 8. Int J Cancer. 2011. PMID: 20715115 Free article.
449 results